Who am I?
Consultant strategist providing competitive and market intelligence to investors in the biopharmaceutical industry ; founder of Qstat Consulting, a boutique strategic consulting firm specialized in competitive markets in Life Sciences industry [http://www.qstatconsulting.com]. In this role, I drive market and competitive intelligence research (primary & secondary) to enable investment strategies and translate findings into critical insights.
What do we offer?
Depending on the requested depth of analysis, we provide primary and secondary research for Key Intelligence Topics (KITs) and Key Intelligence Questions (KIQs).
Under a professional code of conduct, the consultant legally and ethically identify corporate information using a questionnaire technique.
We provide insights and detailed forecast of corporate strategies, which are essential for an investment decision making-process (e.g. the exact release date of trial data, any side-effects, safety or lack of efficacy to be further investigated, go-to-market plans, pricing structure, global regulatory and medical activities)
The secondary framework combines data about the company, drug(s) of interest (summary, patents and generics, regulatory, pre-marketing, preclinical and clinical activities, pricing, market target), marketing research, upcoming milestones, internal strengths and weaknesses, external opportunities and threats, competitive profile matrix (innovation, use of corporate assets, financial soundness, long-term investment, global competitiveness, acquisition, product diversification, product quality, marketing, R&D, patents...)
Primary and secondary data can be combined together to create a full-report, which confidential data are essential in the investment strategy.
Robert Graf is an independent investor and educator with a 20+ year academic background in neuroscience, pharmaceutical sciences and pharmacology. He focuses his attention on index options, top performing companies, commodities, and is a student of price action. He is founder, President, and Chief Broker of Golden Gate Properties where he focuses on building value, creating and retaining wealth with a combination of paper and hard assets.
Robert graduated from the University of California at Berkeley (AB) and from the University of Hawai'i in Honolulu (Ph.D). As an educator, he has spent over ten years as assistant and associate professor of pharmaceutical sciences teaching about clinical trials as well as all major drug classes in use today. Dr. Graf has published in international journals, and is best known for his contributions to the field of crustacean neuronal cell culture and founding the circuit buffer theory of Alzheimer's Disease.